Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts-Reference-Cited by-同舟云学术

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts

Published:2018-05-25 Issue:9 Volume:103 Page:3169-3182
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Marlow Laura A¹,Rohl Stephen D¹,Miller James L¹,Knauf Jeffery A²³,Fagin James A²³,Ryder Mabel¹⁴,Milosevic Dragana⁵,Netzel Brian C⁵,Grebe Stefan K⁵,Reddi Honey V⁶,Smallridge Robert C¹⁷,Copland John A¹

Affiliation:

1. Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida

2. Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York

3. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

4. Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota

5. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

6. Jackson Laboratory of Genomic Medicine, Farmington, Connecticut

7. Division of Endocrinology, Internal Medicine Department, Mayo Clinic, Jacksonville, Florida

Funder

National Institutes of Health

Bankhead-Coley Foundation

Mayo Clinic

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/103/9/3169/25685854/jc.2017-01845.pdf

Reference63 articles.

1. National Cancer Institute. Cancer stat facts: thyroid cancer. Available at: seer.cancer.gov/statfacts/html/thyro.html. Accessed 1 August 2017.

2. Integrated genomic characterization of papillary thyroid carcinoma;Cancer Genome Atlas Research Network;Cell,2014

3. Thyroid cancer cell lines: an overview;Saiselet;Front Endocrinol (Lausanne),2012

4. Highly prevalent TERT promoter mutations in aggressive thyroid cancers;Liu;Endocr Relat Cancer,2013

5. Is poorly differentiated thyroid cancer poorly characterized;Burman;J Clin Endocrinol Metab,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer;Molecular Imaging and Biology;2024-08-22

2. PET Imaging of Differentiated Thyroid Cancer with TSHR-Targeted [⁸⁹Zr]Zr-TR1402;Molecular Pharmaceutics;2024-07-08

3. Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives;Panminerva Medica;2024-06

4. Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer;2024-03-17

5. Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer;Molecular Cancer Therapeutics;2024-03-05